Hypogonadism and male obesity: focus on unresolved questions

M Grossmann - Clinical Endocrinology, 2018 - Wiley Online Library
Obesity, increasing in prevalence globally, is the clinical condition most strongly associated
with lowered testosterone concentrations in men and presents as one of the strongest …

Testosterone replacement therapy and cardiovascular disease: balancing safety and risks in hypogonadal men

K Blackwell, M Blackwell, T Blackwell - Current Cardiology Reports, 2023 - Springer
Abstract Purpose of Review The purpose of this review is to analyze the link between
testosterone replacement therapy (TRT) and adverse cardiovascular (CV) events. Recent …

[HTML][HTML] Age-related changes in the male reproductive system

S Bhasin, RJ Valderrábano, T Gagliano-Jucá - Endotext [Internet], 2022 - ncbi.nlm.nih.gov
In male mammals, changes at all levels of the hypothalamic-pituitary-testicular axis,
including alterations in the GnRH pulse generator, gonadotropin secretion, and testicular …

Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of …

J Ory, S Nackeeran, NC Balaji, JM Hare… - The Journal of …, 2022 - auajournals.org
Purpose: An unsafe hematocrit threshold for men receiving testosterone therapy (TT) has
never been tested. This study seeks to determine whether secondary polycythemia among …

Sex hormone regulation of proteins modulating mitochondrial metabolism, dynamics and inter-organellar cross talk in cardiovascular disease

S Lynch, JE Boyett, MR Smith… - Frontiers in Cell and …, 2021 - frontiersin.org
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. Sex-
related disparities have been identified in the presentation and incidence rate of CVD …

The medicalization of testosterone: reinventing the elixir of life

T Gagliano-Jucá, M Alvarez, S Basaria - Reviews in Endocrine and …, 2022 - Springer
The pursuit of longevity, which during the Renaissance era was limited to longing for
miraculous ways of rejuvenation, such as bathing in the fountain of youth, took a scientific …

Testosterone aggravates cerebral vascular injury by reducing plasma HDL levels

T **, L Wang, D Li, T Yang, Y Zhou - Open Life Sciences, 2020 - degruyter.com
Testosterone is often used to improve the physiological function. But increased testosterone
levels affect blood lipids and cause inflammation and oxidative stress, which are risk factors …

[PDF][PDF] Emerging evidences in the long standing controversy regarding testosterone replacement therapy and cardiovascular events

J Clavell-Hernández, R Wang - The world journal of men's …, 2018 - synapse.koreamed.org
The increasing rate of late-onset hypogonadism has led to an exceptional growth in the use
of testosterone therapy (TTh). Even though TTh has been used for more than 70 years, there …

Conclusions about testosterone therapy and cardiovascular risk

BD Anawalt, BB Yeap - Asian Journal of Andrology, 2018 - journals.lww.com
In this issue of Asian Journal of Andrology (AJA), several experts have reviewed the latest
data on the potential and known effects of endogenous and exogenous testosterone (T) on …

Why is understanding the relationship of testosterone to cardiovascular risk so important?

BB Yeap, BD Anawalt - Asian Journal of Andrology, 2018 - journals.lww.com
Epidemiological studies hint at a beneficial influence of endogenous circulating testosterone
(T), or its metabolite dihydrotestosterone (DHT), such that men with lower concentrations of T …